| 216-LB: Genetic Influences on Beta-Cell Function before Type 1 Diabetes Diagnosis | | | Journal | 2023 | 10.2337/db23-216-LB | TN18, TN22, TN19, TN02, TN05, TN07, TN08, TN09, TN10, TN14, TN01 | 22822 | Secondary Research |
| C-peptide and metabolic outcomes in trials of disease
modifying therapy in new-onset type 1 diabetes:
an individual participant meta-analysis | | | Journal | 2023 | 10.1016/S2213-8587(23)00267-X | TN09, TN08, TN05, TN07, TN10, TN14, TN19, TN02, TN16, TN01 | 23803 | Secondary Research |
| C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes | 37931637 | | Journal | 2023 | 10.1016/S2213-8587(23)00267-X | TN05, TN02, TN08, TN14, TN09 | 23803 | Secondary Research |
| CO-STIMULATION BLOCKADE DISRUPTS CD4+ T-CELL MEMORY PATHWAYS AND UNCOUPLES THEIR LINK TO DECLINE IN β-CELL FUNCTION IN TYPE 1 DIABETES | 32404353 | PMC7378361 | Journal | 2020 | 10.4049/jimmunol.1901439 | TN09 | 21159, 22453 | Secondary Research |
| Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies | 37186151 | PMC10349195 | Journal | 2023 | 10.1002/psp4.12973 | TN10 | 23240 | Secondary Research |
| Genetic Associations with C-peptide Levels before Type 1 Diabetes Diagnosis in At-Risk Relatives | 38767115 | | Journal | 2024 | 10.1210/clinem/dgae349 | TN14, TN19, TN18, TN02, TN05, TN07, TN08, TN09, TN10, TN01 | 22822 | Secondary Research |
| IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes | 34747368 | PMC8663550 | Journal | 2021 | 10.1172/jci.insight.150074 | TN05 | 22487, 23199 | Secondary Research |
| T1dCteGui: A User-Friendly Clinical Trial Enrichment Tool to Optimize Type-1 Diabetes Prevention Studies by Leveraging AI/ML based Synthetic Patient Population | 37326252 | | Journal | 2023 | 10.1002/cpt.2976 | DPT-1, TN10, TN07, TN01, TEDDY | 21437 | Secondary Research |
| Towards Antigen-specific Tregs for Type 1 Diabetes: Construction and Functional Assessment of Pancreatic Endocrine Marker, HPi2-based Chimeric Antigen Receptor | 33068914 | PMC7655659 | Journal | 2020 | 10.1016/j.cellimm.2020.104224 | TN02 | 22487 | Secondary Research |
| Type 1 Diabetes Prevention Clinical Trial Simulator: A Tutorial with Case Examples | 38961520 | | Journal | 2024 | | TN10 | 23240 | Secondary Research |
| Type 1 Diabetes Risk Phenotypes Using Cluster Analysis | 37873281 | PMC10593014 | Journal | 2023 | 10.1101/2023.10.10.23296375 | TN18, TN20, TN19, TN02, TN05, TN07, TN08, TN09, TN10, TN14, TN01 | 22822 | Secondary Research |
| Understanding and preventing type 1 diabetes through the unique working model of TrialNet | 28770323 | PMC5838353 | Journal | 2017 | 10.1007/s00125-017-4384-2 | TN02 | 20540, 20541, 20542, 20691, 20755, 21159, 21169 | Secondary Research |
